title: [New developments in psychiatry].
abstract: Three issues are discussed: i) While number of psychiatric beds has been reduced in most countries and although treatments proposed in psychiatric hospitals have evolved, they continue to be viewed as asylums implementing constraints. Considering this prevents their adequate use and leads to patients' stigmatisation, promotion of a better knowledge of contemporary hospital treatments is needed. 2) In addition, most psychiatric disorders emerging during adolescence and early adulthood, it is important to develop accessible care on university campuses. 3) While risk of weight gain and metabolic syndrome under neuroleptics or mood stabilisers is known, there is a need for the development of <<red flags>> that are easy to identify. A 5% increase in weight during the first month of treatment indicates the risk for important later weight gain.
authors.forename: Philippe
authors.initials: P
authors.lastname: Conus
authors.forename: Fabrice
authors.initials: F
authors.lastname: Herrera
authors.forename: Sylvie
authors.initials: S
authors.lastname: Berney
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Gailland
authors.forename: Véronique
authors.initials: V
authors.lastname: Beretta
authors.forename: Frederik
authors.initials: F
authors.lastname: Vandenberghe
authors.forename: Chin B
authors.initials: CB
authors.lastname: Eap
mesh_terms: D000293:Adolescent; D006778:Hospitals, Psychiatric / Q000458:organization & administration*; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D011570:Psychiatry / Q000639:trends*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D013240:Stereotyping; D055815:Young Adult
chemical_list: D011619:Psychotropic Drugs